Skip to main content
. Author manuscript; available in PMC: 2018 Mar 15.
Published in final edited form as: Clin Cancer Res. 2017 Jun 14;23(18):5366–5373. doi: 10.1158/1078-0432.CCR-17-0645

Table 2.

most frequent grade ≥ 2 adverse events

Adverse event N (% frequency)
Constipation 8 (53.3)
Dry mouth 5 (33.3)
Fatigue 5 (33.3)
Diarrhea 5 (33.3)
Dyspnea 5 (33.3)
Decreased appetite 4 (26.7)
Vomiting 4 (26.7)
Dry Skin 4 (26.7)
Breath Sounds Abnormal 4 (26.7)
Dry eye 3 (20.0)
Stomatitis 3 (20.0)
Epistaxis 3 (20.0)
Hyperphosphatemia 3 (20.0)
Nausea 2 (13.3)
Asthenia 2 (13.3)
Onychomadesis 2 (13.3)
HHS Vulnerability Disclosure